why choose us

First received: January 27, 2023

Clinical Trial: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lassa Virus Infection

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Two-Part (SAD and MAD) Study to Assess the Safety, Tolerability, and Pharmacokinetics of ARN-75039 When Administered By The Orally Route in Hea

Brief Summary: This is a randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and pharmacokinetics (PK) of escalating single ascending dose (SAD) and multiple ascending doses (MAD) of ARN-75039 when administered by the oral route in healthy adult subjects.The SAD portion of the study will enroll approximately 40 subjects for a total duration of 6 weeks.A cohort of 8 subjects in the SAD portion of the study will be selected to assess food effect (including relative bioavailability).The MAD…

Read more